Contact Dermatitis Associated With Nail Care Products: Retrospective Analysis of North American Contact Dermatitis Group Data, 2001-2016.


Journal

Dermatitis : contact, atopic, occupational, drug
ISSN: 2162-5220
Titre abrégé: Dermatitis
Pays: United States
ID NLM: 101207335

Informations de publication

Date de publication:
Historique:
pubmed: 2 5 2020
medline: 25 3 2021
entrez: 2 5 2020
Statut: ppublish

Résumé

Ingredients in nail care products may lead to allergic and/or irritant contact dermatitis. The aims of this study were to determine frequency of contact dermatitis associated with nail care products, characterize associated body sites, and describe causative allergens. A retrospective analysis was conducted with the North American Contact Dermatitis Group data between 2001 and 2016. Of the 38,775 patients tested, 769 (2.0%) had: 1) more than 1 allergic patch test reaction associated with a nail care product (n = 746), 2) irritant contact dermatitis associated with a nail care product (n = 14), or 3) both (n = 9). Primary body sites included the face (43.0%) and hands (27.6%). The top 5 allergens were (2-hydroxyethyl methacrylate (273/482, 56.6%), methyl methacrylate (210/755, 27.8%), ethyl acrylate (190/755, 25.2%), ethyl-2-cyanoacrylate (12/175, 6.9%) and tosylamide (273/755, 36.2%). Frequency of allergy to 2-hydroxyethyl methacrylate (P = 0.0069) and ethyl acrylate (P = 0.0024) significantly increased over the study period, whereas allergy secondary to tosylamide significantly decreased (P < 0.0001). As long-lasting nail techniques become widespread, the prevalence of contact dermatitis to nail care products is expected to increase. Almost one-fifth of nail care product-associated allergens would have been missed without additional screening allergens beyond the North American Contact Dermatitis Group series, underscoring the need for testing to a broad array of allergens.

Sections du résumé

BACKGROUND BACKGROUND
Ingredients in nail care products may lead to allergic and/or irritant contact dermatitis.
OBJECTIVE OBJECTIVE
The aims of this study were to determine frequency of contact dermatitis associated with nail care products, characterize associated body sites, and describe causative allergens.
METHODS METHODS
A retrospective analysis was conducted with the North American Contact Dermatitis Group data between 2001 and 2016.
RESULTS RESULTS
Of the 38,775 patients tested, 769 (2.0%) had: 1) more than 1 allergic patch test reaction associated with a nail care product (n = 746), 2) irritant contact dermatitis associated with a nail care product (n = 14), or 3) both (n = 9). Primary body sites included the face (43.0%) and hands (27.6%). The top 5 allergens were (2-hydroxyethyl methacrylate (273/482, 56.6%), methyl methacrylate (210/755, 27.8%), ethyl acrylate (190/755, 25.2%), ethyl-2-cyanoacrylate (12/175, 6.9%) and tosylamide (273/755, 36.2%). Frequency of allergy to 2-hydroxyethyl methacrylate (P = 0.0069) and ethyl acrylate (P = 0.0024) significantly increased over the study period, whereas allergy secondary to tosylamide significantly decreased (P < 0.0001).
CONCLUSIONS CONCLUSIONS
As long-lasting nail techniques become widespread, the prevalence of contact dermatitis to nail care products is expected to increase. Almost one-fifth of nail care product-associated allergens would have been missed without additional screening allergens beyond the North American Contact Dermatitis Group series, underscoring the need for testing to a broad array of allergens.

Identifiants

pubmed: 32355091
doi: 10.1097/DER.0000000000000583
doi:

Substances chimiques

Acrylates 0
Cosmetics 0
Cyanoacrylates 0
Methacrylates 0
Tosyl Compounds 0
Methylmethacrylate 196OC77688
ethyl 2-cyanoacrylate 2G95FOH7SF
hydroxyethyl methacrylate 6E1I4IV47V
ethyl acrylate 71E6178C9T

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-201

Auteurs

Erin M Warshaw (EM)

From the Department of Dermatology, Park Nicollet Health Services, Minneapolis.
Department of Dermatology, University of Minnesota, Minneapolis.
Department of Dermatology, Minneapolis Veterans Affairs Medical Center.

Lindsey M Voller (LM)

From the Department of Dermatology, Park Nicollet Health Services, Minneapolis.
Department of Dermatology, Minneapolis Veterans Affairs Medical Center.
University of Minnesota Medical School, Minneapolis.

Jonathan I Silverberg (JI)

Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL.

Joel G DeKoven (JG)

Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.

Amber R Atwater (AR)

Department of Dermatology, Duke University, Durham, NC.

Howard I Maibach (HI)

Department of Dermatology, University of California San Francisco.

Margo J Reeder (MJ)

Department of Dermatology, University of Wisconsin Medical School, Madison, WI.

Denis Sasseville (D)

Division of Dermatology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.

Donald V Belsito (DV)

Department of Dermatology, Columbia University, New York, NY.

Vincent A DeLeo (VA)

Department of Dermatology, Keck School of Medicine of USC, Los Angeles, CA.

Anthony F Fransway (AF)

Associates in Dermatology, Fort Myers, FL.

Joseph F Fowler (JF)

University of Louisville, KY.

James S Taylor (JS)

Department of Dermatology, Cleveland Clinic, OH.

Melanie D Pratt (MD)

Division of Dermatology, University of Ottawa, Ontario, Canada.

Toby Mathias (T)

Department of Dermatology, University of Cincinnati, OH.

James G Marks (JG)

Department of Dermatology, Pennsylvania State University, State College.

Kathryn A Zug (KA)

Dartmouth-Hitchcock Medical Center, Lebanon, NH.

Matthew J Zirwas (MJ)

Department of Dermatology, Ohio State University, Columbus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH